GAI
GILD icon

General American Investors’s Gilead Sciences GILD Stock Holding History

General American Investors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100,000
Closed -$257K – 75
2021
Q1 		$257K Buy
+100,000
New +$6.45M 0.02% 66

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

General American Investors's GILD Position: Q2 2026 in Review

General American Investors increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $3.29M and bringing the position to 144,900 shares worth $18.3M. The position accounts for 1.08% of the portfolio, ranked #30.

General American Investors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $49.6M in Q2 2015. 1,509 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • General American Investors held 144,900 shares of Gilead Sciences worth $18.3M as of Q2 2026.
  • General American Investors bought 25,000 Gilead Sciences shares in Q2 2026, an estimated $3.29M.
  • Gilead Sciences made up 1.08% of General American Investors's portfolio in Q2 2026, its #30 holding.
  • General American Investors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • General American Investors's Gilead Sciences position peaked at $49.6M in Q2 2015.
  • 1,509 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on General American Investors's 13F filing for Q2 2026, filed 31 Jul 2026.